These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 10340555)

  • 41. Prospects for herpes-simplex-virus thymidine-kinase and cytokine gene transduction as immunomodulatory gene therapy for prostate cancer.
    Hassan W; Sanford MA; Woo SL; Chen SH; Hall SJ
    World J Urol; 2000 Apr; 18(2):130-5. PubMed ID: 10854148
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer.
    Hall SJ; Canfield SE; Yan Y; Hassen W; Selleck WA; Chen SH
    Gene Ther; 2002 Apr; 9(8):511-7. PubMed ID: 11948376
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene transfer into human prostate adenocarcinoma cells with an adenoviral vector: Hyperthermia enhances a double suicide gene expression, cytotoxicity and radiotoxicity.
    Lee YJ; Lee H; Borrelli MJ
    Cancer Gene Ther; 2002 Mar; 9(3):267-74. PubMed ID: 11896443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Animal experiment on gene therapy of ovarian cancer by adenovirus-mediated thymidine kinase gene transduction and ganciclovir administration in vivo].
    Tong X; Sei W; Gu M
    Zhonghua Fu Chan Ke Za Zhi; 1997 Dec; 32(12):712-4. PubMed ID: 9772431
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term outcome of phase I/II clinical trial of Ad-OC-TK/VAL gene therapy for hormone-refractory metastatic prostate cancer.
    Shirakawa T; Terao S; Hinata N; Tanaka K; Takenaka A; Hara I; Sugimura K; Matsuo M; Hamada K; Fuji K; Okegawa T; Higashihara E; Gardner TA; Kao C; Chung LW; Kamidono S; Fujisawa M; Gotoh A
    Hum Gene Ther; 2007 Dec; 18(12):1225-32. PubMed ID: 18021019
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel mechanism of synergistic cytotoxicity with 5-fluorocytosine and ganciclovir in double suicide gene therapy.
    Boucher PD; Im MM; Freytag SO; Shewach DS
    Cancer Res; 2006 Mar; 66(6):3230-7. PubMed ID: 16540675
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adenoviral-mediated thymidine kinase gene transfer into the primate brain followed by systemic ganciclovir: pathologic, radiologic, and molecular studies.
    Goodman JC; Trask TW; Chen SH; Woo SL; Grossman RG; Carey KD; Hubbard GB; Carrier DA; Rajagopalan S; Aguilar-Cordova E; Shine HD
    Hum Gene Ther; 1996 Jun; 7(10):1241-50. PubMed ID: 8793548
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adenoviral-mediated herpes simplex virus thymidine kinase gene transfer: regression of hepatic metastasis of pancreatic tumors.
    Block A; Chen SH; Kosai K; Finegold M; Woo SL
    Pancreas; 1997 Jul; 15(1):25-34. PubMed ID: 9211489
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
    Kajiwara E; Kawano K; Hattori Y; Fukushima M; Hayashi K; Maitani Y
    J Control Release; 2007 Jul; 120(1-2):104-10. PubMed ID: 17509714
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced pancreatic tumor regression by a combination of adenovirus and retrovirus-mediated delivery of the herpes simplex virus thymidine kinase gene.
    Carrió M; Romagosa A; Mercadé E; Mazo A; Nadal M; Gómez-Foix AM; Fillat C
    Gene Ther; 1999 Apr; 6(4):547-53. PubMed ID: 10476214
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Killing effect of adenovirus vector-mediated herpes simplex virus thymidine kinase gene recombinant construct on various cancer cells].
    Zhou JF; Chen G; Lu YP; Wang SX; Ma D
    Ai Zheng; 2003 Dec; 22(12):1264-7. PubMed ID: 14693048
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeted expression of herpes simplex virus thymidine kinase in adenovirus-infected cells reduces virus titers upon treatment with ganciclovir in vitro.
    Ibrišimović M; Nagl U; Kneidinger D; Rauch M; Lion T; Klein R
    J Gene Med; 2012 Jan; 14(1):3-19. PubMed ID: 22190534
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adenovirus vector-mediated herpes simplex virus-thymidine kinase gene/ganciclovir system exhibits anti-tumor effects in an orthotopic hepatocellular carcinoma model.
    Zhu R; Chen D; Lin D; Lu F; Yin J; Li N
    Pharmazie; 2014 Jul; 69(7):547-52. PubMed ID: 25073402
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses.
    Sandmair AM; Loimas S; Puranen P; Immonen A; Kossila M; Puranen M; Hurskainen H; Tyynelä K; Turunen M; Vanninen R; Lehtolainen P; Paljärvi L; Johansson R; Vapalahti M; Ylä-Herttuala S
    Hum Gene Ther; 2000 Nov; 11(16):2197-205. PubMed ID: 11084677
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of potent antitumor natural killer cell activity by herpes simplex virus-thymidine kinase and ganciclovir therapy in an orthotopic mouse model of prostate cancer.
    Hall SJ; Sanford MA; Atkinson G; Chen SH
    Cancer Res; 1998 Aug; 58(15):3221-5. PubMed ID: 9699645
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intracerebral injection of adenovirus harboring the HSVtk gene combined with ganciclovir administration: toxicity study in nonhuman primates.
    Driesse MJ; Vincent AJ; Sillevis Smitt PA; Kros JM; Hoogerbrugge PM; Avezaat CJ; Valerio D; Bout A
    Gene Ther; 1998 Aug; 5(8):1122-9. PubMed ID: 10326036
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhanced therapeutic effect of HSV-tk+GCV gene therapy and ionizing radiation for prostate cancer.
    Chhikara M; Huang H; Vlachaki MT; Zhu X; Teh B; Chiu KJ; Woo S; Berner B; Smith EO; Oberg KC; Aguilar LK; Thompson TC; Butler EB; Aguilar-Cordova E
    Mol Ther; 2001 Apr; 3(4):536-42. PubMed ID: 11319915
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Retrovirus-mediated herpes simplex virus thymidine kinase gene transduction renders human thyroid carcinoma cell lines sensitive to ganciclovir and radiation in vitro and in vivo.
    Nishihara E; Nagayama Y; Mawatari F; Tanaka K; Namba H; Niwa M; Yamashita S
    Endocrinology; 1997 Nov; 138(11):4577-83. PubMed ID: 9348181
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo characterization of a prostate-specific antigen promoter-based suicide gene therapy for the treatment of benign prostatic hyperplasia.
    Park HS; Cheon J; Cho HY; Ko YH; Bae JH; Moon DG; Kim JJ
    Gene Ther; 2003 Jul; 10(13):1129-34. PubMed ID: 12808443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.